Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's versioning.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision log updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous v3.4.2.SummaryDifference0.0%

- Check97 days agoChange DetectedA new Revision: v3.4.2 is shown, and the prior Revision: v3.4.1 notice is removed. The changes appear to be site-wide UI/notice updates rather than updates to the study details.SummaryDifference0.3%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.